Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| Market Size (2025) | USD 10.55 Billion |
| Market Size (2030) | USD 14.81 Billion |
| Growth Rate (2025 - 2030) | 7.01% CAGR |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
USA Artificial Organs And Bionic Implants Market Analysis by Mordor Intelligence
The USA Artificial Organs & Bionic Implants Market size is estimated at USD 10.55 billion in 2025, and is expected to reach USD 14.81 billion by 2030, at a CAGR of 7.01% during the forecast period (2025-2030).
The growth of the market in the country can be attributed to the increasing incidence of disabilities and organ failures and technological advancements leading to enhanced applications.
The demand for organ donors is ever increasing and is very high when compared to the actual supply. It has been estimated that, of all the patients who need organ transplantation, only 10% are able to undergo the process. This has been a major boost for artificial organs and the bionics market, as the patients cannot afford to wait in the queue since the stakes are very high. Bionics and artificial organs can cater to those in need of organ transplantations and replacements, as they can replicate the function of damaged organs.
Furthermore, the technological advancements and the increasing healthcare expenditure in the country is boosting the market growth. However, the high cost of the organs and the procedures is a major constraint. The high cost of these organs is due to the production policies to address the patients, taxpayers, and medical technology corporations. Additionally, fear of device malfunction and its consequences, and limited specialists to carry out the procedure, are also restraining the growth of the artificial organs and bionic implants market.
USA Artificial Organs And Bionic Implants Market Trends and Insights
Cardiac Bionics Segment is Expected to Have a Highest Growth Rate in the Forecast Period
Cardiac bionics consist of heart valves, ventricular assisted devices, pacemakers, others. The high growth rate of the segment is attributed to the increasing prevalence of cardiovascular diseases associated with the increasing geriatric population in the United States.
According to Centres for Disease Control and Prevention, 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. It has been found that one person dies every 37 seconds in the United States from cardiovascular disease. There are about 647,000 Americans die from heart disease each year that is 1 in every 4 deaths. Heart disease is also found costing the United States about USD 219 billion each year. Therefore with the large patient pool in the country, the cardiac bionic segment maintains its dominant position throughout the forecast period.
Competitive Landscape
The USA Artificial Organs and Bionic Implants Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product development. Some of the major players in the market are ABIOMED, Boston Scientific Corporation, Berlin Heart GmbH, Edward Lifesciences Corporation, Otto Bock Holding GmbH & Co. KG, LifeNet Health, and Medtronic plc.
USA Artificial Organs And Bionic Implants Industry Leaders
Boston Scientific Corporation
Berlin Heart GmbH
Edward Lifesciences Corporation
Abiomed Inc.
Otto Bock Holding GmbH & Co. KG
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
USA Artificial Organs And Bionic Implants Market Report Scope
As per the scope of the report, artificial organs are mechanical devices that can temporarily or permanently substitute for a body organ. The Artificial Organs are made by a human and are implemented in human bodies with living tissue, it can able to perform the original function of human body parts. Bionics refers to the replacement or improvement of body parts by mechanical kinds.
By Product
| Artificial Organs | Artificial Heart |
| Artificial Kidney | |
| Cochlear Implants | |
| Others | |
| Bionics | Vision Bionics |
| Ear Bionics | |
| Orthopedic Bionic | |
| Cardiac Bionics | |
| Others |
| By Product | Artificial Organs | Artificial Heart |
| Artificial Kidney | ||
| Cochlear Implants | ||
| Others | ||
| Bionics | Vision Bionics | |
| Ear Bionics | ||
| Orthopedic Bionic | ||
| Cardiac Bionics | ||
| Others | ||
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the USA Artificial Organs & Bionic Implants Market?
The USA Artificial Organs & Bionic Implants Market size is expected to reach USD 10.55 billion in 2025 and grow at a CAGR of 7.01% to reach USD 14.81 billion by 2030.
What is the current USA Artificial Organs & Bionic Implants Market size?
In 2025, the USA Artificial Organs & Bionic Implants Market size is expected to reach USD 10.55 billion.
Who are the key players in USA Artificial Organs & Bionic Implants Market?
Boston Scientific Corporation, Berlin Heart GmbH, Edward Lifesciences Corporation, Abiomed Inc. and Otto Bock Holding GmbH & Co. KG are the major companies operating in the USA Artificial Organs & Bionic Implants Market.
What years does this USA Artificial Organs & Bionic Implants Market cover, and what was the market size in 2024?
In 2024, the USA Artificial Organs & Bionic Implants Market size was estimated at USD 9.81 billion. The report covers the USA Artificial Organs & Bionic Implants Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the USA Artificial Organs & Bionic Implants Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
